Clinical trials
Terminated Cholangiocarcinoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| BioNTech SE | 1 |
| Concordia Laboratories Inc. | 1 |
| Elevation Oncology | 1 |
| Helsinn Healthcare SA | 1 |
| Incyte Corporation | 1 |
| NRG Oncology | 1 |
| NuCana plc | 1 |
| POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | 1 |
| QED Therapeutics, a BridgeBio company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 13 |
| Bile Duct Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
| Esophageal Neoplasms | 3 |
| Gallbladder Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Colorectal Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Sarcoma | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.